120 related articles for article (PubMed ID: 3126183)
21. Construction and expression of a hybrid plasminogen activator gene with sequences from non-protease region of tissue-type plasminogen activator (t-PA) and protease region of urokinase (u-PA).
Kalyan NK; Lee SG; Cheng SM; Hartzell R; Urbano C; Hung PP
Gene; 1988 Sep; 68(2):205-12. PubMed ID: 3146528
[TBL] [Abstract][Full Text] [Related]
22. Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator.
Hansen L; Blue Y; Barone K; Collen D; Larsen GR
J Biol Chem; 1988 Oct; 263(30):15713-9. PubMed ID: 3139674
[TBL] [Abstract][Full Text] [Related]
23. [Expression and activity of tissue-type plasminogen activator mutant reteplase with deletion of PAI-1 binding sites].
Zhu MC; Zhan Z; Wang YJ; Liu CG; Shi Y; Cai Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):565-9. PubMed ID: 16143058
[TBL] [Abstract][Full Text] [Related]
24. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
Stewart RJ; Fredenburgh JC; Leslie BA; Keyt BA; Rischke JA; Weitz JI
J Biol Chem; 2000 Apr; 275(14):10112-20. PubMed ID: 10744692
[TBL] [Abstract][Full Text] [Related]
25. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.
Collen D; Lijnen HR; Bulens F; Vandamme AM; Tulinsky A; Nelles L
J Biol Chem; 1990 Jul; 265(21):12184-91. PubMed ID: 2115513
[TBL] [Abstract][Full Text] [Related]
27. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.
Verheijen JH; Caspers MP; Chang GT; de Munk GA; Pouwels PH; Enger-Valk BE
EMBO J; 1986 Dec; 5(13):3525-30. PubMed ID: 3030730
[TBL] [Abstract][Full Text] [Related]
28. N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line.
Parekh RB; Dwek RA; Rudd PM; Thomas JR; Rademacher TW; Warren T; Wun TC; Hebert B; Reitz B; Palmier M
Biochemistry; 1989 Sep; 28(19):7670-9. PubMed ID: 2514793
[TBL] [Abstract][Full Text] [Related]
29. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
[TBL] [Abstract][Full Text] [Related]
30. Comparison of recombinant tissue-type plasminogen activator (rt-PA) expressed in mouse C127 cells and human vascular plasminogen activator (HV-PA).
Hamaguchi M; Takahashi I; Takehara T; Takamatsu J; Saito H
Biochim Biophys Acta; 1989 Nov; 1009(2):143-50. PubMed ID: 2508748
[TBL] [Abstract][Full Text] [Related]
31. Newer thrombolytic agents.
Verstraete M
Ann Acad Med Singap; 1999 May; 28(3):424-33. PubMed ID: 10575530
[TBL] [Abstract][Full Text] [Related]
32. A protease-hypersensitive deletion derivative of human tissue-type plasminogen activator.
Weidle UH; Buckel P; Mattes R
Gene; 1988 Dec; 73(2):439-47. PubMed ID: 3149609
[TBL] [Abstract][Full Text] [Related]
33. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.
Lijnen HR; Li XK; Nelles L; Hu MH; Collen D
Eur J Biochem; 1992 Apr; 205(2):701-9. PubMed ID: 1533368
[TBL] [Abstract][Full Text] [Related]
34. Design of a novel chimeric tissue plasminogen activator with favorable Vampire bat plasminogen activator properties.
Kazemali M; Majidzadeh-A K; Sardari S; Saadatirad AH; Khalaj V; Zarei N; Barkhordari F; Adeli A; Mahboudi F
Enzyme Microb Technol; 2014 Dec; 67():82-6. PubMed ID: 25442953
[TBL] [Abstract][Full Text] [Related]
35. Construction and expression of a recombinant antibody-targeted plasminogen activator.
Schnee JM; Runge MS; Matsueda GR; Hudson NW; Seidman JG; Haber E; Quertermous T
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6904-8. PubMed ID: 3116546
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
Fleury V; Lijnen HR; Anglés-Cano E
J Biol Chem; 1993 Sep; 268(25):18554-9. PubMed ID: 8103046
[TBL] [Abstract][Full Text] [Related]
37. Biological properties of hybrid plasminogen activators.
Hung PP; Wilhelm J; Kalyan NK; Cheng SM; James HL; Nachowiak D; Weinheimer CJ; Sobel BE; Bergmann SR; Lee SG
Adv Exp Med Biol; 1990; 281():201-8. PubMed ID: 2129369
[TBL] [Abstract][Full Text] [Related]
38. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis.
Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH
Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
Fischer BE
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
[TBL] [Abstract][Full Text] [Related]
40. Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator.
Yamada M; Horiuchi T; Oribe T; Yamamoto S; Sugie I; Gentry PA
Vet Res Commun; 1997 Feb; 21(2):75-84. PubMed ID: 9061881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
